{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:09:42Z","timestamp":1788307782478,"version":"build-2803163510"},"reference-count":23,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T00:00:00Z","timestamp":1493769600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0175539","type":"journal-article","created":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T17:31:35Z","timestamp":1493832695000},"page":"e0175539","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Bell\u2019s palsy and influenza(H1N1)pdm09 containing vaccines: A self-controlled case series"],"prefix":"10.1371","volume":"12","author":[{"given":"Leonoor","family":"Wijnans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8784-696X","authenticated-orcid":true,"given":"Caitlin N.","family":"Dodd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Weibel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Sturkenboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,5,3]]},"reference":[{"issue":"13","key":"ref1","first-page":"1323","article-title":"Clinical practice. Bell's Palsy","volume":"351","author":"DH Gilden","year":"2004","journal-title":"The New England journal of medicine"},{"issue":"1","key":"ref2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1046\/j.1468-1331.2002.00343.x","article-title":"The epidemiology and treatment of Bell's palsy in the UK","volume":"9","author":"S Rowlands","year":"2002","journal-title":"Eur J Neurol"},{"issue":"4","key":"ref3","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1159\/000338303","article-title":"Epidemiologic and clinical features of Bell's palsy among children in Northern California","volume":"38","author":"A Rowhani-Rahbar","year":"2012","journal-title":"Neuroepidemiology"},{"issue":"1","key":"ref4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vaccine.2007.10.043","article-title":"All that palsies is not Bell's -the need to define Bell's palsy as an adverse event following immunization","volume":"26","author":"B Rath","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"ref5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.autrev.2012.05.008","article-title":"Bell's palsy and autoimmunity","volume":"12","author":"A Greco","year":"2012","journal-title":"Autoimmunity reviews"},{"issue":"7465","key":"ref6","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1136\/bmj.329.7465.553","article-title":"Recent developments in Bell's palsy","volume":"329","author":"NJ Holland","year":"2004","journal-title":"BMJ"},{"issue":"15","key":"ref7","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1016\/j.vaccine.2006.10.006","article-title":"Bell's palsy associated with influenza vaccination: two case reports","volume":"25","author":"CH Chou","year":"2007","journal-title":"Vaccine"},{"issue":"20","key":"ref8","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1016\/j.vaccine.2012.02.080","article-title":"A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in adults 18\u201349 years of age","volume":"30","author":"R Baxter","year":"2012","journal-title":"Vaccine"},{"issue":"19","key":"ref9","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1016\/j.vaccine.2012.02.039","article-title":"A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 5 through 17 years of age","volume":"30","author":"R Baxter","year":"2012","journal-title":"Vaccine"},{"issue":"21","key":"ref10","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1001\/jama.294.21.2720","article-title":"Adverse events reported following live, cold-adapted, intranasal influenza vaccine","volume":"294","author":"HS Izurieta","year":"2005","journal-title":"JAMA: the journal of the American Medical Association"},{"issue":"9","key":"ref11","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland","volume":"350","author":"M Mutsch","year":"2004","journal-title":"The New England journal of medicine"},{"issue":"8","key":"ref12","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/pds.998","article-title":"A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)\u2014United States, 1991\u20132001","volume":"13","author":"W Zhou","year":"2004","journal-title":"Pharmacoepidemiology and drug safety"},{"issue":"3","key":"ref13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4161\/hv.2790","article-title":"Bell's palsy and parenteral inactivated influenza vaccine","volume":"2","author":"J Stowe","year":"2006","journal-title":"Human vaccines"},{"issue":"9","key":"ref14","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1093\/aje\/kws011","article-title":"Immunization and Bell's palsy in children: a case-centered analysis","volume":"175","author":"A Rowhani-Rahbar","year":"2012","journal-title":"American journal of epidemiology"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"d5956","DOI":"10.1136\/bmj.d5956","article-title":"Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden","volume":"343","author":"C Bardage","year":"2011","journal-title":"BMJ"},{"issue":"2","key":"ref16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.amepre.2011.04.004","article-title":"H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project","volume":"41","author":"GM Lee","year":"2011","journal-title":"American journal of preventive medicine"},{"issue":"12","key":"ref17","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/j.vaccine.2012.01.013","article-title":"The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: a capture-recapture analysis","volume":"30","author":"WT Huang","year":"2012","journal-title":"Vaccine"},{"issue":"10","key":"ref18","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1002\/sim.2302","article-title":"Tutorial in biostatistics: the self-controlled case series method","volume":"25","author":"HJ Whitaker","year":"2006","journal-title":"Statistics in medicine"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.2307\/2533328","article-title":"Relative incidence estimation from case series for vaccine safety evaluation","volume":"51","author":"CP Farrington","year":"1995","journal-title":"Biometrics"},{"issue":"4","key":"ref20","first-page":"251","article-title":"Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates","volume":"19","author":"BT Blak","year":"2011","journal-title":"Informatics in primary care"},{"issue":"4","key":"ref21","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/pds.1335","article-title":"Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research","volume":"16","author":"JD Lewis","year":"2007","journal-title":"Pharmacoepidemiology and drug safety"},{"key":"ref22","unstructured":"Department of Health. Pandemic H1N1 (swine) influenza vaccine uptake amongst patient groups in primary care in England 2009\/10. In: DH\/HPA28, editor. Oct 2010."},{"issue":"12","key":"ref23","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1017\/S0950268811001531","article-title":"Use of the self-controlled case-series method in vaccine safety studies: review and recommendations for best practice","volume":"139","author":"YG Weldeselassie","year":"2011","journal-title":"Epidemiology and infection"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0175539","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T21:01:41Z","timestamp":1588971701000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0175539"}},"subtitle":[],"editor":[{"given":"Chris T.","family":"Bauch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,5,3]]},"references-count":23,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0175539","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,3]]}}}